
Walter Cazzaniga
@waltercazzaniga
ID: 1273387688
16-03-2013 21:51:18
108 Tweet
93 Followers
265 Following

🚨don't miss: tomorrow: Inês Santiago, Walter Cazzaniga with other great panelists will discuss a case about Seminoma Stage IIB. What are the therapy options? Purple area, eURO auditorium 2 🟣 #EAU24


Explore the nuances of retro. If u are interested in renal surgery, tailor your approach on pts and tumors characteristics and standardize your technique Alberto Breda European Association of Urology (EAU) Fundació Puigvert Barcelona


Long-term QOL of #GCT patients according to adj treatment pubmed.ncbi.nlm.nih.gov/38658465/ Crucial data informing impact of RPLND, chemo, XRT in CSI and >CSI GCT patients. Surveillance preferred option, but this can guide discussion! Sia Daneshmand, M.D. Scott Eggener Phillip Pierorazio nirm

As usual, amazing work from Rob Hamilton team on microRNAS in the MRD setting! qPCR serum and plasma vs ddPCR. Critically important work! Matthew Murray Lucia Nappi João Lobo Lindsay Frazier Malignant Germ Cell International Consortium




Dr. David Nicol (The Royal Marsden NHS Foundation Trust) with the final talk of GU Pathology Society (GUPS) Virtual Education Series event on Germ Cell Tumors: Beyond the Usual TOPIC: Clinical Management of Advanced/Metastatic Germ Cell Tumors #gupath #testicularcancer ROHIT MEHRA Sounak Gupta








Words of Wisdom Wednesday: Re: Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office by Walter Cazzaniga and David Nicol Read the full


Excellent discussion by Clint Cary, MD MPH MBA #GU25 following Axel Heidenreich’s long term followup of COTRIMS trial. Surgery for early metastatic seminoma. Appreciate continuous efforts to improve on already excellent curative outcomes with #RPLND alone. #SEMS. Testicular Cancer Society Testicular Cancer



